Las acciones de Abbott Laboratories se cotizaban a EUR 88,79 el 30 de septiembre de 2026, mientras que el EPS ajustado del segundo trimestre reac

Descubra cómo Grace Groner transformó una modesta inversión de $180 en Abbott Laboratories en 1935 en una fortuna de $7 millones, apoyando a los estudiantes con su legado después de su fallecimiento.

Abbott Laboratories (ABT) expanded its presence in cancer screening with the launch of SimpleScreen CRC in the US. The test is an FDA-approved blood-based option for average-risk adults who decline traditional colorectal screening methods. Against that product backdrop, Abbott Laboratories has seen its 1 month share price return fall about 10.2%, while the 90 day share price return is up 9.5%. This points to fading short term momentum compared with a still positive multi quarter trend. Recent...

Abbott Laboratories has seen its share price retreat over the past year, which puts the spotlight squarely on whether the current market value lines up with the cash the business is expected to generate. For investors already holding Abbott stock or thinking about starting a position, the question now is how well the recent share price reflects those cash flows. The share price has fallen 22.9% over the past year, which raises the issue of whether the recent slide has brought the valuation...

Las acciones de Abbott cotizaban a 88,67 euros fuera de horario a las 8:09 p.m. CEST el 29 de septiembre de 2026, un descenso del 0,11 por ciento

Get the latest Abbott Laboratories (ABT) stock news and headlines to help you in your trading and investment decisions.

Abbott Laboratories stock was at EUR 88.71, versus the EUR 88.77 prior close and minus 0.07 percent

Abbott Laboratories cotizó por última vez a USD 100,95 el 28 de septiembre de 2026, un 0,34 por ciento menos que el precio inicial.

Una mujer de Pensilvania presentó una demanda contra Abbott Laboratories y Abbott Medical, alegando que los dispositivos defectuosos de estimulación de la médula espinal le provocaron un empeoramiento del dolor, lesiones neurológicas y otras complicaciones de salud.

Gilead Sciences, Inc. (NASDAQ:GILD) y Abbott Laboratories (NYSE:ABT) devuelven efectivo a los accionistas a través de dividendos, pero las empresas que respaldan esos pagos son muy diferentes. Actualmente, Gilead está creciendo más rápido, impulsado por una franquicia de VIH que continúa ganando impulso, mientras que Abbott ofrece una diversificación considerablemente mayor en dispositivos médicos, diagnóstico, nutrición y productos farmacéuticos establecidos, como […]

With long term Treasury yields hitting multi decade highs and mortgage rates pressing above 7.3%, income investors are watching both bond and equity markets with unusual urgency. Higher borrowing costs can pressure many businesses; however, some large U.S. dividend payers have cash flows and payout habits that may hold up better when rates stay elevated. This article walks through three U.S. Large Cap Defensive Dividend Stocks from our screener that appear especially exposed to today’s rate...